Alcon Inc., CH0432492467

Jefferies keeps Buy rating on Alcon stock at USD 85 target

Published on 10/06/2026 at 09:16 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Alcon posted USD 2.82 billion revenue in the second quarter of 2026. Alcon stock costs EUR 57.01 on October 6, 2026 versus EUR 57.32.

Watercolor illustration of a stylized human eye centered in wide panoramic composition. Iris rendered in intricate pastel rainbow patterns in lavender, mint, peach, gold with delicate ink linework and translucent watercolor washes
Alcon CH0432492467: Aquarell Illustration eines Auges mit bunten Iris Mustern in zarten Pastellfarben, Illustration mit AI erstellt.

Alcon (ISIN CH0432492467) was trading at EUR 57.01 at Lang & Schwarz on October 6, 2026 at 9:13 a.m. CEST, down 0.54 percent versus the prior close of EUR 57.32. In a report released on September 22, 2026, Jefferies analyst Young Li maintained a Buy rating on Alcon and set a USD 85.00 price target, as Markets Insider reported.

Second-quarter revenue beats estimates

Alcon generated USD 2.82 billion of revenue in the second quarter of 2026, compared with a USD 2.77 billion consensus estimate. Adjusted earnings per share reached USD 0.84 against USD 0.77 expected, a 9.10 percent positive surprise, according to Earnings Today.

The reporting period ended June 30, 2026, and the figures were published on August 10, 2026. Operating cash flow was USD 510.0 million in the same quarter, while total assets stood at USD 31.1 billion, giving the revenue beat a cash-flow measure alongside the earnings comparison.

Guidance raises the valuation bar

Alcon lifted its 2026 core earnings growth guidance to 12 percent to 15 percent in constant currency on August 11, 2026, while its core operating margin reached 20.60 percent. The figures and the margin update were reported by DK Street Journal on September 23, 2026.

That combination explains why the analyst target matters more than a bare revenue beat. Jefferies' USD 85.00 target is above the latest NYSE quote, but the euro reference price and the dollar target use different trading venues and currencies, so the comparison is directional rather than a calculated upside figure.

NYSE range keeps risk visible

Alcon's primary NYSE quotation was last shown at USD 64.33 on October 5, 2026, with a USD 61.84 to USD 87.64 52-week range and a market capitalization of USD 31.4 billion. The Lang & Schwarz quote is a separate euro indication for German-market investors.

Alcon's investor-relations stock page lists ticker ALC on the NYSE in USD, confirms ISIN CH0432492467 and includes the company in the Swiss Market Index, according to Alcon. The company operates through Surgical and Vision Care, so the next report will be important for testing whether the earnings growth guidance is broad-based.

Alcon stock stays below its prior close

Alcon was trading at EUR 57.01 at Lang & Schwarz on October 6, 2026 at 9:13 a.m. CEST, down 0.54 percent from the Lang & Schwarz prior close of EUR 57.32 on October 5, 2026. The further course of trading is shown by the continuously updated real-time quote of Alcon stock.

Alcon stock facts

  • Company: Alcon Inc.
  • ISIN: CH0432492467
  • Ticker: ALC
  • Primary exchange: NYSE
  • Price Lang & Schwarz as of October 6, 2026, 9:13 a.m. CEST: EUR 57.01
  • Change versus prior close: minus 0.54 percent
  • Prior close Lang & Schwarz October 5, 2026: EUR 57.32
  • Market capitalization: USD 31.4 billion as of October 5, 2026
  • 52-week range: USD 61.84-87.64 as of October 5, 2026
  • Sector / Industry: Healthcare / Medical Specialties
  • Index membership: Swiss Market Index
  • Next earnings date: November 10, 2026

More news and analyses on Alcon stock

Disclaimer...

en | CH0432492467 | ALCON INC. | boerse | 70239904 | bgmi